Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Current Oncology (Toronto, Ont.)
|
April 26, 2014
The use of granulocyte colony-stimulating factors in a Canadian outpatient setting
S Fine, M Koo, T Gill, et al.
Respiratory Medicine
|
December 19, 2007
The cost of moderate and severe COPD exacerbations to the Canadian healthcare system
N Mittmann, L Kuramoto, S J Seung, et al.
Current Oncology (Toronto, Ont.)
|
March 9, 2017
Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario
S Hassan, S J Seung, M C Cheung, et al.
Pharmacoeconomics
|
December 8, 1996
Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature
K E Agro, C A Bradley, N Mittmann, et al.
Current Oncology (Toronto, Ont.)
|
December 31, 2015
Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer
K Lien, V C Tam, Y J Ko, et al.
Annals of Surgical Oncology
|
July 12, 2017
Patterns and Drivers of Costs for Neuroendocrine Tumor Care: A Comparative Population-Based Analysis
Julie Hallet, C H L Law, M Cheung, et al.
Journal of Cutaneous Medicine and Surgery
|
April 19, 2015
Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous Dermatoses
K Heelan, S L Hitzig, S Knowles, et al.
The Journal of Hospital Infection
|
November 25, 2015
Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs
J A Maslikowska, S A N Walker, M Elligsen, et al.
Pharmacoepidemiology and Drug Safety
|
May 1, 1997
Drug-related mortality in Canada (1984-1994)
N Mittmann, B A Liu, M Iskedjian, et al.
Current Oncology (Toronto, Ont.)
|
April 21, 2011
A Canadian economic analysis of U.S. Oncology Adjuvant Trial 9735
L M Bernard, S Verma, M F Thompson, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Current Oncology (Toronto, Ont.)
|
April 26, 2014
The use of granulocyte colony-stimulating factors in a Canadian outpatient setting
S Fine, M Koo, T Gill, et al.
Respiratory Medicine
|
December 19, 2007
The cost of moderate and severe COPD exacerbations to the Canadian healthcare system
N Mittmann, L Kuramoto, S J Seung, et al.
Current Oncology (Toronto, Ont.)
|
March 9, 2017
Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario
S Hassan, S J Seung, M C Cheung, et al.
Pharmacoeconomics
|
December 8, 1996
Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature
K E Agro, C A Bradley, N Mittmann, et al.
Current Oncology (Toronto, Ont.)
|
December 31, 2015
Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer
K Lien, V C Tam, Y J Ko, et al.
Annals of Surgical Oncology
|
July 12, 2017
Patterns and Drivers of Costs for Neuroendocrine Tumor Care: A Comparative Population-Based Analysis
Julie Hallet, C H L Law, M Cheung, et al.
Journal of Cutaneous Medicine and Surgery
|
April 19, 2015
Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous Dermatoses
K Heelan, S L Hitzig, S Knowles, et al.
The Journal of Hospital Infection
|
November 25, 2015
Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs
J A Maslikowska, S A N Walker, M Elligsen, et al.
Pharmacoepidemiology and Drug Safety
|
May 1, 1997
Drug-related mortality in Canada (1984-1994)
N Mittmann, B A Liu, M Iskedjian, et al.
Current Oncology (Toronto, Ont.)
|
April 21, 2011
A Canadian economic analysis of U.S. Oncology Adjuvant Trial 9735
L M Bernard, S Verma, M F Thompson, et al.
Page
of 6